نتایج جستجو برای: myh9 gene

تعداد نتایج: 1141526  

Journal: :iranian red crescent medical journal 0
effat asdadollahpour medical biotechnology research center, ashkezar branch, islamic azad university, ashkezar, yazd, ir iran maryam daneshpour cellular and molecular endocrine research center, research institute for endocrine sciences, shahid beheshti university of medical sciences, tehran, ir iran bahareh sedaghati khayat cellular and molecular endocrine research center, research institute for endocrine sciences, shahid beheshti university of medical sciences, tehran, ir iran arsalan hashemiaghdam diabetes research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, ir iran mahsa mohammad amoli endocrinology and metabolism research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, ir iran mostafa qorbani department of community medicine, alborz university of medical sciences, karaj, ir iran

conclusions although we found an association between myh9 gene polymorphism and urinary albumin excretion, the results did not show a significant association between myh9 polymorphism (rs4821481) and risk of dn in iranian diabetic patients. background myosin heavy chain 9 (myh9) gene polymorphisms have been implicated in different types of renal disease, as well as in nephropathy attributed to ...

Journal: :Thrombosis and haemostasis 2010
Anna Savoia Daniela De Rocco Emanuele Panza Valeria Bozzi Raffaella Scandellari Giuseppe Loffredo Andrew Mumford Paula G Heller Patrizia Noris Marco R De Groot Marisa Giani Paolo Freddi Francesca Scognamiglio Silvia Riondino Núria Pujol-Moix Fabrizio Fabris Marco Seri Carlo L Balduini Alessandro Pecci

MYH9-related disease ( MYH9-RD) is an autosomal dominant thrombocytopenia with giant platelets variably associated with young-adult onset of progressive sensorineural hearing loss, presenile cataract, and renal damage. MYH9-RD is caused by mutations of MYH9 , the gene encoding for non-muscle heavy-chain myosin-9. Wild-type and mutant myosin-9 aggregate as cytoplasmic inclusions in patients' leu...

Journal: :Kidney international 2009
Barry I Freedman Pamela J Hicks Meredith A Bostrom Mary E Cunningham Yongmei Liu Jasmin Divers Jeffrey B Kopp Cheryl A Winkler George W Nelson Carl D Langefeld Donald W Bowden

African Americans have high incidence rates of end-stage renal disease (ESRD) labeled as due to hypertension. As recent studies showed strong association with idiopathic and HIV-related focal segmental glomerulosclerosis and non-muscle myosin heavy chain 9 (MYH9) gene polymorphisms in this ethnic group, we tested for MYH9 associations in a variety of kidney diseases. Fifteen MYH9 single-nucleot...

Journal: :Seminars in thrombosis and hemostasis 2009
Karina Althaus Andreas Greinacher

Myosin heavy chain 9 (MYH9)-related platelet disorders belong to the group of inherited thrombocytopenias. The MYH9 gene encodes the nonmuscle myosin heavy chain IIA (NMMHC-IIA), a cytoskeletal contractile protein. Several mutations in the MYH9 gene lead to premature release of platelets from the bone marrow, macrothrombocytopenia, and cytoplasmic inclusion bodies within leukocytes. Four overla...

2017
Mengxia Yu Jinghan Wang Zhijuan Zhu Chao Hu Qiuling Ma Xia Li Xiufeng Yin Jiansong Huang Ting Zhang Zhixin Ma Yile Zhou Chenying Li Feifei Chen Jian Chen Yungui Wang Hanzhang Pan Dongmei Wang Jie Jin

MYH9 expression has previously been demonstrated as an independent predictor of clinical outcome in solid tumors. However, the prognostic relevance of MYH9 expression in acute myeloid leukemia is still unclear. Here, we found high MYH9 expressers were seen more frequently in females and more frequently in M4 morphology. We also found high MYH9 expressers had lower percentage of bone marrow blas...

2014
Vinícius Sardão Colares Silvia Maria de Oliveira Titan Alexandre da Costa Pereira Patrícia Malafronte Mari M. Cardena Sidney Santos Paulo C. Santos Cíntia Fridman Rui Toledo Barros Viktória Woronik

MYH9 polymorphisms have been described to be associated with the risk of CKD in non-diabetic nephropathy, HIV nephropathy and FSGS. Predominating in black descendants, MHY9 genetic variants could partially explain the excess risk of CKD associated with African ancestry. However, recent data suggests that APOL1 gene co-segregate with MYH9, and could be the gene truly associated with CKD risk. In...

Journal: :Genetics and molecular research : GMR 2015
C Ling C Y Cai B C Chang W T Shi F J Wei P Yu L M Chen W D Li

Genetic factors play an important role in type 2 diabetes (T2D) complications. Alteration of cerebrovascular blood flow (CBF) is a direct result of cerebrovascular diseases. However, few studies have reported the role of genetics on CBF in patients with T2D. We investigated whether single-nucleotide polymorphisms (SNPs) in metabolic disease genes are associated with CBF in patients with T2D. CB...

Journal: :Haematologica 2006
Edmond S K Ma Chris L P Wong Tony W H Shek S P Hui

We describe a Chinese family with an MYH9-related disorder in which a novel mutation V1516L at exon 31 of the MYH9 gene was identified. To the best of our knowledge, this is the first reported Chinese family with MYH9 mutation and supports the pan-ethnic nature of the disorder.

2017
Rengeng Liu Qianyu Zhang Yuehong Lang Zibo Tang Zhongzhong Peng Xiaojun Cai Zhaojian Fu Weiyi Fang Libo Li

MYH9 (myosin, heavy chain 9, non-muscle) as a gene encodes NM II-A (non-muscle II-A) protein, exists primarily in the cytoplasm. MYH9 consists of 2 mysoin heavy chains with a relative molecular mass of 230 kDa. Previous studies have shown that MYH9 is involved in a number of diseases, including cancer. However, the exact role of MYH9 in colon cancer is still unclear. Therefore, we used a tissue...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012
Jessica N Cooke Meredith A Bostrom Pamela J Hicks Maggie C Y Ng Jacklyn N Hellwege Mary E Comeau Jasmin Divers Carl D Langefeld Barry I Freedman Donald W Bowden

BACKGROUND Polymorphisms in the non-muscle myosin IIA gene (MYH9) are associated with focal segmental glomerulosclerosis (FSGS) and non-diabetic end-stage renal disease (ESRD) in African Americans and FSGS in European Americans. We tested for association of single nucleotide polymorphisms (SNPs) in MYH9 with T2DM-ESRD in European Americans; additionally, three APOL1 gene variants were evaluated...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید